http://www.hnykdxxb.com/PDF/202014/01.pdf

http://www.hnykdxxb.com/PDF/202014/01.pdf

Objective: THigh-risk non-invasive bladder cancer (NMIBC) has a high rate of recurrence and disease progression. At present, there are still insufficient effective prevention and treatment methods, especially for patients who have failed BCG treatment. This article reviews the research progress o...

Full description

Bibliographic Details
Main Authors:	Xin-Ming Hu, Lei Xu
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2020-07-01
Series:	Journal of Hainan Medical University
Subjects:	bcg unresponsive non-muscle invasive bladder cancer disease progression immunotherapy
Online Access:	http://www.hnykdxxb.com/PDF/202014/11.pdf

Similar Items

http://www.hnykdxxb.com/PDF/201904/01.pdf
by: Gang Dai, et al.
Published: (2019-02-01)

http://www.hnykdxxb.com/PDF/201620/39.pdf
by: Wei Lu, et al.
Published: (2016-10-01)

http://www.hnykdxxb.com/PDF/201716/20.pdf
by: Ru Chen, et al.
Published: (2019-09-01)

http://www.hnykdxxb.com/PDF/201917/3.pdf
by: Yang Xiao-jie, et al.
Published: (2019-09-01)

Study on the correlation between TCM syndrome differentiation and immune inflammation index of Sjogren's syndromehttp://www.hnykdxxb.com/PDF/202114/01.pdf
by: Gui-Zhen Wang
Published: (2021-07-01)

Survey and analysis ohttp://www.hnykdxxb.com/PDF/202009/01.pdff anxiety of 804 residents in Hainan during the COVID-19 epidemic
by: Guo-Tian Lin, et al.
Published: (2020-05-01)

Does restaging transurethral resection of bladder tumor influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
by: Wojciech Krajewski, et al.
Published: (2018-12-01)

http://www.jonnpr.com/pdf/1076.pdf
by: J. Manuel Martínez Sesmero, et al.
Published: (2016-12-01)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
by: Jungyo Suh, et al.
Published: (2021-08-01)

http://www.aulamedica.es/fh/pdf/8547.pdf
by: Rosa María Damas Fuentes, et al.
Published: (2015-01-01)

http://www.aulamedica.es/fh/pdf/1129.pdf
by: R. López-Sepúlveda, et al.
Published: (2014-01-01)

http://www.aulamedica.es/fh/pdf/10518.pdf
by: Marta García-Queiruga, et al.
Published: (2016-05-01)

http://www.aulamedica.es/fh/pdf/10689.pdf
by: Marta García-Queiruga, et al.
Published: (2017-03-01)

http://www.aulamedica.es/fh/pdf/7860.pdf
by: Carmen Haro Márquez, et al.
Published: (2015-01-01)

http://www.utgjiu.ro/revista/ec/pdf/2009-01/14_MASINI_FABIO.pdf
by: Odzaklieska Dragica
Published: (2009-05-01)

http://www.mii.lt/informatics_in_education/pdf/INFE067.pdf
by: Athanasis KAROULIS
Published: (2006-04-01)

Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience
by: Vivek Sharma, et al.
Published: (2020-12-01)

Miliary Tuberculosis Due to BCG Immunotherapy
by: Bilgehan AYGEN, et al.
Published: (1996-03-01)

https://www.jonnpr.com/pdf/935.pdf
by: Jesús M. Culebras
Published: (2016-06-01)

TREATMENT IN PATIENTS WITH MUSCLE NONINVASIVE CARCINOMA OF THE URINARY BLADDER AFTER UNSUCCESSFUL INTRAVESICULAR BCG THERAPY
by: K. M. Figurin
Published: (2014-07-01)

TREATMENT IN PATIENTS WITH MUSCLE NONINVASIVE CARCINOMA OF THE URINARY BLADDER AFTER UNSUCCESSFUL INTRAVESICULAR BCG THERAPY
by: K. M. Figurin
Published: (2014-07-01)

MAINTENANCE INTRAVESICULAR THERAPY WITH BCG VACCINE AS A STANDARD FOR THE PREVENTION AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN MODERATE AND HIGH RISK GROUPS
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer
by: Charles J. Rosser, et al.
Published: (2021-01-01)

MAINTENANCE INTRAVESICULAR THERAPY WITH BCG VACCINE AS A STANDARD FOR THE PREVENTION AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN MODERATE AND HIGH RISK GROUPS
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer
by: Holz S, et al.
Published: (2017-09-01)

Mechanism of Genetically-Regulated Response to Bacillus- Calmette Guérin Immunotherapy for Bladder Cancer
by: Hakeem Sam, et al.
Published: (2020-12-01)

Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
by: Jiansong Han, et al.
Published: (2020-09-01)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
by: Florus C. de Jong, et al.
Published: (2021-03-01)

http://www.business-inform.net/export_pdf/business-inform-2019-6_0-pages-40_46.pdf
by: Lymar Valeriia V., et al.
Published: (2019-06-01)

http://www.business-inform.net/export_pdf/business-inform-2017-3_0-pages-41_45.pdf
by: Us Tetiana V.
Published: (2017-03-01)

Protective role of intravesical BCG in COVID-19 severity
by: Héctor Gallegos, et al.
Published: (2021-03-01)

Does the Decrease in Neutrophil-lymphocyte Ratio after BCG Treatment Be a Prognostic Marker for NMIBC?
by: Aykut Başer
Published: (2020-12-01)

NONMUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF URINARY BLADDER – ADJUVANT INTRAVESICAL THERAPIES AFTER TRANSURETHRAL TUMOR RESECTION
by: Nicolae Grigore, et al.
Published: (2017-09-01)

Bacilo Calmette-Guerin (BCG) e enterotoxina B do Staphylococcus aureus (EBS) no tratamento do câncer não músculo invasivo de bexiga urinária de ratos
by: Reis, Leonardo Oliveira, 1978-
Published: (2011)

Prospects for the use of the method of intravesical hyperthermic chemotherapy in the treatment of patients with non-muscle invasive bladder cancer
by: Roman Chystiakov
Published: (2021-04-01)

http://www.athensjournals.gr/education/2017-4-1-5-Zervas.pdf
by: Theodore G. Zervas
Published: (2017-02-01)

http://www.growingscience.com/ijiec/Vol7/IJIEC_2015_26.pdf
by: Vinod Kumar, et al.
Published: (2015-08-01)

http://www.derecho.uba.ar/publicaciones/lye/revistas/90/abreut.pdf
by: Abreut de Begher, Liliana
Published: (2012-12-01)

Monthly maintenance protocol Bacillus Calmette–Guerin as a viable alternative to Southwest Oncology Group maintenance protocol in nonmuscle-invasive bladder cancer: A prospective randomized study
by: Naveen Kumar Gupta, et al.
Published: (2020-01-01)

http://www.omjournal.org/fultext_PDF.aspx?DetailsID=629&type=fultext
by: Yasir Khayyat, et al.
Published: (2015-03-01)